miltefosine has been researched along with itraconazole in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SC; Guse, Z; Halliday, C; Jolliffe, KA; Kong, F; Lee, OC; Sorrell, TC; Tong, Z; Widmer, F; Wright, LC | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Braga, SS | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Barragán, P; López-Velez, R; Olmo, M; Podzamczer, D | 1 |
| Borba-Santos, LP; de Souza, W; Gagini, T; Ishida, K; Rozental, S | 1 |
| El-Khordagui, LK; El-Moslemany, RM; El-Sheridy, NA; Helmy, MW; Ramadan, AA | 1 |
| Abastabar, M; Aghili, SR; Akhtari, J; Al Hatmi, AMS; Al-Harrasi, A; Badali, H; Haghani, I; Hajheydari, Z; Hedayati, MT; Javidnia, J; Kermani, F; Khojasteh, S; Moazeni, M; Shokohi, T; Yahyazadeh, Z | 1 |
1 review(s) available for miltefosine and itraconazole
| Article | Year |
|---|---|
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
7 other study(ies) available for miltefosine and itraconazole
| Article | Year |
|---|---|
In vitro activities of miltefosine and two novel antifungal biscationic salts against a panel of 77 dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Cations; Chlorides; Humans; Microbial Sensitivity Tests; Phosphorylcholine; Pyridinium Compounds; Quaternary Ammonium Compounds | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.
Topics: AIDS-Related Opportunistic Infections; HIV; HIV Infections; HIV-1; Humans; Itraconazole; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Opportunistic Infections; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Recurrence; Treatment Failure | 2010 |
Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Brazil; Cell Line; Cell Membrane; Cell Survival; Cell Wall; Cytoplasm; Drug Resistance, Fungal; Epithelial Cells; Humans; Itraconazole; Macaca mulatta; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Phosphorylcholine; Sporothrix; Sporotrichosis | 2015 |
Enhancing the
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Drug Liberation; Female; Hedgehog Proteins; Humans; Itraconazole; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanocapsules; Neovascularization, Pathologic; Particle Size; Phosphorylcholine; Random Allocation | 2021 |
Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains.
Topics: Antifungal Agents; Aspergillus; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |